Skip to content
Monday, February 6, 2023
Latest:
  • SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
  • Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
  • Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
  • PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin
  • MindMed Announces Inclusion in FTSE Russell Indexes
Biotech Stock Market News

Biotech Stock Market News

Know First, Act First

  • Cannabis & Cancer
  • General
  • Coronavirus
  • Financing & Fiscal
  • Shareholders

Financing & Fiscal

BIOTCHNO Financing & Fiscal 

Willow Biosciences Provides Update on Acceleration of Expiry Date of Outstanding Warrants Issued Pursuant to October 2020 Unit Financing

March 3, 2021June 2, 2021 Raza

Canada NewsWire VANCOUVER, BC , March 3, 2021 /CNW/ – Willow Biosciences Inc. (” Willow ” or the ” Company “) (TSX: WLLW)

Read more
BIOTCHNO Financing & Fiscal 

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company

February 19, 2021April 30, 2021 Bachittar

Canada NewsWire Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive

Read more
BIOTCHNO Financing & Fiscal 

SQI Diagnostics Announces New Corporate Website

February 18, 2021April 30, 2021 Bachittar

Canada NewsWire New Website Provides Essential Information on Company’s Strategic Initiative TORONTO,Feb. 18, 2021/CNW/ – SQI Diagnostics Inc. (the “Company”

Read more
BIOTCHNO Financing & Fiscal 

Menarini Silicon Biosystems announces launch of CellMag(TM) product line offering affordable Gold Standard Circulating Tumor Cells capture

February 16, 2021April 30, 2021 Bachittar

  CELLMAG – a cost effective, manual and simple approach for the enrichment and staining of extremely rare cells from

Read more
BIOTCHNO Financing & Fiscal 

Inova Appoints Claude Basset as Chief Product Officer

February 8, 2021April 30, 2021 Bachittar

Canada NewsWire LYON, France, Feb. 8, 2021 /PRNewswire/ — Inova, the market-leading partnering platform for the pharmaceutical and biotech industry, today announced that Claude

Read more
BIOTCHNO Financing & Fiscal 

Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs

January 18, 2021April 20, 2021 vanessa

Canada NewsWire Rolontis and Oraxol BLA/NDA approval from U.S. FDA is expected within this year LAPSTriple Agonist, an innovative triple-acting

Read more

Cannabis

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
BIOTCHNO Cannabis & Cancer 

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan

March 31, 2021July 19, 2021 Raza

TOKYO, Mar 31, 2021 – (JCN Newswire) – Eisai Co., Ltd. and MSD K.K. a subsidiary of Merck & Co.,

The Valens Company Expands Cannabis 2.0 & 3.0
BIOTCHNO Cannabis & Cancer 

The Valens Company Expands Cannabis 2.0 & 3.0

February 25, 2021April 20, 2021 Bachittar
PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation
BIOTCHNO Cannabis & Cancer 

PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation

February 16, 2021April 30, 2021 Bachittar
ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium
BIOTCHNO Cannabis & Cancer 

ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium

February 11, 2021April 30, 2021 Bachittar
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057